Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Roberts: Court action to make KC a patent troll haven will squash innovation
Editor’s note: Melissa Roberts is urging the Kansas City business community to sign a petition that aims to halt an effort to establish Kansas City as an area friendly to “patent trolls.” The commenting period on the proposed changes closes 5 p.m., Nov. 26. The opinions in the commentary are the author’s alone. I used…
Nick Ward-Bopp: Local maker community harkens to KC’s creative roots
Editor’s Note: Nick Ward-Bopp co-manages the MakerSpace at the Johnson County Library, helping the community use tools for digital fabrication like 3D printers and laser cutters. He also spends his nights and weekends co-running Maker Village — a small wood and metal shop in Midtown Kansas City — where it focused on building community through workshops…
Kansas City’s slow, steady entrepreneurial growth nabs No. 23 ranking
For the second year in a row, Kansas City maintained its rank as No. 23 out of 40 metros in entrepreneurial activity, according to the Ewing Marion Kauffman Foundation’s 2016 Main Street Entrepreneurship report. The annual report covers the rate of business owners, established small business density, survival rate and more. These metrics are calculated…
Report: Area Latino business ownership surged in 2015
Latino business ownership is on the rise in the Kansas City area, according to a recent study. While area entrepreneurial activity has largely remained steady, the percent of Latinos that own businesses in Kansas City considerably increased from 2014 to 2015, according to the Ewing Marion Kauffman Foundation’s Index of Main Street Entrepreneurship. Now just…